{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:35:03Z","timestamp":1794490503376,"version":"4.9.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2019,7,2]]},"abstract":"<jats:p>Recent developments in cancer therapeutics have improved outcomes but have also been associated with cardiovascular complications. Therapies harnessing the immune system have been associated with an immune-mediated myocardial injury described as myocarditis. Immune checkpoint inhibitors are one such therapy with an increasing number of case and cohort reports describing a clinical syndrome of immune checkpoint inhibitor\u2013associated myocarditis. Although the full spectrum of immune checkpoint inhibitor\u2013associated cardiovascular disease still needs to be fully defined, described cases of myocarditis range from syndromes with mild signs and symptoms to fatal events. These observations in the clinical setting stand in contrast to outcomes from randomized clinical trials in which myocarditis is a rare event that is investigator reported and lacking in a specific case definition. The complexities associated with diagnosis, as well as the heterogeneous clinical presentation of immune checkpoint inhibitor\u2013associated myocarditis, have made ascertainment and identification of myocarditis with high specificity challenging in clinical trials and other data sets, limiting the ability to better understand the incidence, outcomes, and predictors of these rare events. Therefore, establishing a uniform definition of myocarditis for application in clinical trials of cancer immunotherapies will enable greater understanding of these events. We propose an operational definition of cancer therapy-associated myocarditis that may facilitate case ascertainment and report and therefore may enhance the understanding of the incidence, outcomes, and risk factors of this novel clinical syndrome.<\/jats:p>","DOI":"10.1161\/circulationaha.118.034497","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T14:00:22Z","timestamp":1561989622000},"page":"80-91","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":441,"title":["Myocarditis in the Setting of Cancer Therapeutics"],"prefix":"10.1161","volume":"140","author":[{"given":"Marc P.","family":"Bonaca","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine (M.P.B., B.A.O., S.D.W., G.C.S., M.D.C.), Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Olenchock","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine (M.P.B., B.A.O., S.D.W., G.C.S., M.D.C.), Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."},{"name":"Regeneron Pharmaceuticals, Inc, Tarrytown, NY (B.A.O.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe-Elie","family":"Salem","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Clinical Pharmacology, Cardio-Oncology Program (J.E.S., J.M.), Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN."},{"name":"Division of Oncology (J.E.S., J.M., D.B.J.), Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN."},{"name":"UNICO APHP.6 Cardio-Oncology Program (J.E.S., S.E., A.C.)."},{"name":"Sorbonne Universit\u00e9, INSERM Clinical Investigaton Center Paris-Est, Assistance Publique - Hopitaux de Paris, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Department of Pharmacology, Paris, France (J.E.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Wiviott","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine (M.P.B., B.A.O., S.D.W., G.C.S., M.D.C.), Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Ederhy","sequence":"additional","affiliation":[{"name":"UNICO APHP.6 Cardio-Oncology Program (J.E.S., S.E., A.C.)."},{"name":"Service de cardiologie H\u00f4pitaux Universitaires Est Parisien, H\u00f4pital Saint Antoine, Assistance Publique\u2013H\u00f4pitaux de Paris, INSERM 856, Sorbonne-universit\u00e9, France (S.E.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Cohen","sequence":"additional","affiliation":[{"name":"UNICO APHP.6 Cardio-Oncology Program (J.E.S., S.E., A.C.)."},{"name":"Sorbonne-Universit\u00e9 and INSERM 856, H\u00f4pital Saint Antoine, Paris, France (A.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrick C.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine (M.P.B., B.A.O., S.D.W., G.C.S., M.D.C.), Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni K.","family":"Choueiri","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (T.K.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Di Carli","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine (M.P.B., B.A.O., S.D.W., G.C.S., M.D.C.), Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[{"name":"Sorbonne University, AP-PH, Piti\u00e9 Salp\u00eatri\u00e8re Hospital, Department of Internal Medicine and Clinical Immunology, Paris, France (Y.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharam J.","family":"Kumbhani","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX (D.J.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Heinzerling","sequence":"additional","affiliation":[{"name":"University Hospital Erlangen, Department of Dermatology, Germany (L.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laleh","family":"Amiri-Kordestani","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD (L.A.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Lyon","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital, London, United Kingdom (A.R.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paaladinesh","family":"Thavendiranathan","sequence":"additional","affiliation":[{"name":"Peter Munk Cardiac Centre, Ted Rogers Program in Cardiotoxicity Prevention and Department of Medical Imaging, University Health Network, University of Toronto, Ontario, Canada (P.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Padera","sequence":"additional","affiliation":[{"name":"Department of Pathology (R.P., A.L.), Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lichtman","sequence":"additional","affiliation":[{"name":"Department of Pathology (R.P., A.L.), Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Liu","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Cellular &amp; Molecular Medicine, University of Ottawa Heart Institute, Ontario, Canada (P.P.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Clinical Pharmacology, Cardio-Oncology Program (J.E.S., J.M.), Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN."},{"name":"Division of Oncology (J.E.S., J.M., D.B.J.), Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Moslehi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Clinical Pharmacology, Cardio-Oncology Program (J.E.S., J.M.), Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN."},{"name":"Division of Oncology (J.E.S., J.M., D.B.J.), Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1100265"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.010484"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.07.025"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609214"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-017-0835-0"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709684"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801946"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000296"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030571"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30533-6"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.037"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.3009"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30608-9"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2017.11.036"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz026"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1706169"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708566"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-490565"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006034"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0296-4"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049259"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0828-282X(06)70908-4"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx321"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-1910-0"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-1-8"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)90226-3"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70116-X"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.017"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev302"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.11.069"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.02.007"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000118493.13323.81"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.3350"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029289"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.033502"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.118.034497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:45:35Z","timestamp":1715571935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.118.034497"}},"subtitle":["Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology"],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7,2]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.118.034497"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.118.034497","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"2019-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}